465 filings
Page 14 of 24
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
27 Jun 18
Current report (foreign)
5:27pm
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
27 Jun 18
Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018
5:01pm
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
12 Jun 18
Acasti Pharma Reports on Positive Feedback Following Today’s Presentation at the XVIII International Symposium on Atherosclerosis
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
8 Jun 18
Current report (foreign)
5:00pm
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
6 Jun 18
Acasti Pharma to Present at the XVIII(th) International Symposium on Atherosclerosis
7:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
5 Jun 18
Acasti Pharma Appoints Brian Groch as Chief Commercial Officer
12:00am
D
ACST
Acasti Pharma Inc - Ordinary Shares
25 May 18
$837.55K in equity / options / securities to be acquired, sold $372.64K, 1 investor
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
18 May 18
Current report (foreign)
8:44am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 May 18
Acasti Pharma Announces Full Exercise of Over-Allotment Option
2:32pm
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
9 May 18
Acasti Pharma Announces Closing of $10 Million Underwritten Offering
5:17pm
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
27 Apr 18
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
8:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
24 Apr 18
Acasti Pharma Prices CDN$10 Million Underwritten Offering in Canada
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
24 Apr 18
Acasti Pharma Announces Overnight Marketed Canadian Public Unit Offering
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
2 Apr 18
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
12:00am
EFFECT
ACST
Acasti Pharma Inc - Ordinary Shares
16 Mar 18
Notice of effectiveness
12:00am
CORRESP
ACST
Acasti Pharma Inc - Ordinary Shares
15 Mar 18
Correspondence with SEC
12:00am
6-K
ACST
Acasti Pharma Inc - Ordinary Shares
14 Mar 18
Acasti Pharma Announces First Patient Randomized in Pivotal TRILOGY Phase 3 Program
12:00am
UPLOAD
ACST
Acasti Pharma Inc - Ordinary Shares
12 Mar 18
Letter from SEC
12:00am
F-3
ACST
Acasti Pharma Inc - Ordinary Shares
6 Mar 18
Shelf registration (foreign)
12:00am
424B3
ACST
Acasti Pharma Inc - Ordinary Shares
15 Feb 18
Prospectus supplement
12:00am